1. Home
  2. CYPH vs SFWL Comparison

CYPH vs SFWL Comparison

Compare CYPH & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CYPH

Cypherpunk Technologies Inc.

N/A

Current Price

$1.22

Market Cap

73.4M

Sector

Health Care

ML Signal

N/A

Logo Shengfeng Development Limited

SFWL

Shengfeng Development Limited

HOLD

Current Price

$0.88

Market Cap

72.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
SFWL
Founded
2011
2001
Country
United States
China
Employees
6
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
73.4M
72.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CYPH
SFWL
Price
$1.22
$0.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0M
10.4K
Earning Date
05-13-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.06
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.56
52 Week High
$3.70
$1.29

Technical Indicators

Market Signals
Indicator
CYPH
SFWL
Relative Strength Index (RSI) 58.21 45.50
Support Level $0.88 $0.86
Resistance Level $1.30 $1.01
Average True Range (ATR) 0.15 0.06
MACD 0.01 0.00
Stochastic Oscillator 55.34 20.69

Price Performance

Historical Comparison
CYPH
SFWL

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services. The company's operations are based in the PRC. Its integrated logistics solutions are comprised of three business streams: B2B freight transportation services; cloud storage services; and value-added services. The company derives maximum revenue from Transportation, followed by Warehouse storage management services. The solutions provides by the company are : Internet TV; Electronic communication; Textiles and Apparel; Automotive parts; and e-commerce.

Share on Social Networks: